The Gainesville Sun reports on Captozyme attending the Florida Venture Capital Conference

A Gainesville biotechnology company has been selected to present at a venture capital conference in Orlando next month.

Captozyme was one of 20 companies selected to participate in the 2017 Florida Venture Capital Conference, out of the more than 100 companies that applied to be a part of the weekend-long event.

The conference will provide Captozyme the opportunity to connect with hundreds of investors from around the world, said Jeanne Becker, a spokeswoman for the event.